This brand name is authorized in United States
The drug FLULAVAL QUADRIVALENT contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Influenza, inactivated, surface antigen
UNII K8A11W1ZVV - INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
|
|
|
|
2
Influenza, inactivated, surface antigen
UNII 2828WNW8HO - INFLUENZA A VIRUS A/HONG KONG/2671/2019 (H3N2) NIB-121 NEURAMINIDASE ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
|
|
|
|
3
Influenza, inactivated, surface antigen
UNII 0LS66T074T - INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
|
|
|
|
4
Influenza, inactivated, surface antigen
UNII H2198F8ZNA - INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
|
|
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: US | FDA, National Drug Code | Identifier(s): 19515-816 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
